Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;41(8):2017-28.
doi: 10.1007/s11064-016-1913-1. Epub 2016 Apr 15.

Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling

S Vandresen-Filho  1   2 , W C Martins  3 , D B Bertoldo  3 , D K Rieger  3 , M Maestri  3 , R B Leal  3 , C I Tasca  3
Affiliations

Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling

S Vandresen-Filho et al. Neurochem Res. 2016 Aug.

Abstract

Statins have been shown to promote neuroprotection in a wide range of neurological disorders. However, the mechanisms involved in such effects of statins are not fully understood. Quinolinic acid (QA) is a neurotoxin that induces seizures when infused in vivo and promotes glutamatergic excitotoxicity in the central nervous system. The aim of this study was to evaluate the putative glutamatergic mechanisms and the intracellular signaling pathways involved in the atorvastatin neuroprotective effects against QA toxicity. Atorvastatin (10 mg/kg) treatment for 7 days prevented the QA-induced decrease in glutamate uptake, but had no effect on increased glutamate release induced by QA. Moreover, atorvastatin treatment increased the phosphorylation of ERK1 and prevented the decrease in Akt phosphorylation induced by QA. Neither atorvastatin treatment nor QA infusion altered glutamine synthetase activity or the levels of phosphorylation of p38(MAPK) or JNK1/2 during the evaluation. Inhibition of MEK/ERK signaling pathway, but not PI3K/Akt signaling, abolished the neuroprotective effect of atorvastatin against QA-induced decrease in glutamate uptake. Our data suggest that atorvastatin protective effects against QA toxicity are related to modulation of glutamate transporters via MAPK/ERK signaling pathway.

Keywords: Akt; Atorvastatin; ERK; Excitotoxicity; Neuroprotection; Quinolinic acid.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Behav Brain Res. 2011 Jan 1;216(1):220-8 - PubMed
    1. PLoS One. 2011;6(8):e22135 - PubMed
    1. Int J Dev Neurosci. 2008 May-Jun;26(3-4):355-62 - PubMed
    1. Eur J Pharmacol. 2007 Feb 14;557(1):76-86 - PubMed
    1. Neuropharmacology. 2005 Nov;49(6):872-82 - PubMed

MeSH terms

LinkOut - more resources